Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

Get Started

DRTX

(MM) (DRTX)

(MM)

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:DRTX

<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 Next >>

Date	Time	Source	Headline	Symbol	Company
02/25/2013	8:09AM	Dow Jones News	Durata Sees Positive Results From Dalbavancin Study	NASDAQ:DRTX	(MM)
02/25/2013	7:00AM	GlobeNewswire Inc.	Durata Therapeutics Announces Preliminary, Topline Phase 3 Clinical Trial Results for Dalbavancin in the Treatment of ABSSSI	NASDAQ:DRTX	(MM)
02/22/2013	6:47PM	Edgar (US Regulatory)	Annual Statement of Changes in Beneficial Ownership (5)	NASDAQ:DRTX	(MM)
02/21/2013	6:04AM	Edgar (US Regulatory)	Annual Statement of Changes in Beneficial Ownership (5)	NASDAQ:DRTX	(MM)
02/20/2013	2:00PM	GlobeNewswire Inc.	Durata Therapeutics to Present at the Cowen & Company 33rd Annual Health Care Conference	NASDAQ:DRTX	(MM)
02/14/2013	6:03PM	Edgar (US Regulatory)	Annual Statement of Changes in Beneficial Ownership (5)	NASDAQ:DRTX	(MM)
02/14/2013	5:59PM	Edgar (US Regulatory)	Annual Statement of Changes in Beneficial Ownership (5)	NASDAQ:DRTX	(MM)
02/14/2013	5:56PM	Edgar (US Regulatory)	Annual Statement of Changes in Beneficial Ownership (5)	NASDAQ:DRTX	(MM)
02/14/2013	5:54PM	Edgar (US Regulatory)	Annual Statement of Changes in Beneficial Ownership (5)	NASDAQ:DRTX	(MM)
02/14/2013	5:53PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:DRTX	(MM)
02/14/2013	5:52PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:DRTX	(MM)
02/14/2013	5:52PM	Edgar (US Regulatory)	Annual Statement of Changes in Beneficial Ownership (5)	NASDAQ:DRTX	(MM)
02/14/2013	5:48PM	Edgar (US Regulatory)	Annual Statement of Changes in Beneficial Ownership (5)	NASDAQ:DRTX	(MM)
02/14/2013	5:47PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:DRTX	(MM)
02/14/2013	5:47PM	Edgar (US Regulatory)	Annual Statement of Changes in Beneficial Ownership (5)	NASDAQ:DRTX	(MM)
02/14/2013	5:43PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:DRTX	(MM)
02/14/2013	5:34PM	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:DRTX	(MM)
02/13/2013	4:00PM	GlobeNewswire Inc.	Durata Therapeutics to Present at the 2013 RBC Capital Markets' Global Healthcare Conference	NASDAQ:DRTX	(MM)
01/04/2013	8:30AM	GlobeNewswire Inc.	Durata Therapeutics Meets Primary Endpoints for EMA Review in Phase 3 Clinical Trial	NASDAQ:DRTX	(MM)
12/11/2012	8:00AM	Business Wire	Durata Therapeutics Announces Phase 3 Clinical Trial Results for Dalbavancin in the Treatment of ABSSSI	NASDAQ:DRTX	(MM)
12/10/2012	4:39PM	Business Wire	Durata Therapeutics to Host Conference Call & Webcast on December 11, 2012 at 9:00AM ET to Present Preliminary Top-line Resul...	NASDAQ:DRTX	(MM)
11/14/2012	10:08AM	Business Wire	Durata Therapeutics Relocating Corporate Headquarters to Chicago	NASDAQ:DRTX	(MM)
11/09/2012	8:51AM	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:DRTX	(MM)
11/09/2012	8:51AM	Edgar (US Regulatory)	Quarterly Report (10-Q)	NASDAQ:DRTX	(MM)
11/09/2012	8:33AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:DRTX	(MM)
11/09/2012	8:33AM	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:DRTX	(MM)
11/09/2012	7:45AM	Business Wire	Durata Therapeutics Reports Third Quarter 2012 Financial and Corporate Results	NASDAQ:DRTX	(MM)
11/08/2012	7:45AM	Business Wire	Durata Therapeutics to Present at Credit Suisse 2012 Healthcare Conference	NASDAQ:DRTX	(MM)
11/05/2012	7:45AM	Business Wire	FDA Designates Durata Therapeutics’ Dalbavancin a Qualified Infectious Disease Product (QIDP)	NASDAQ:DRTX	(MM)
10/25/2012	7:45AM	Business Wire	Durata Therapeutics Completes Target Enrollment in Phase 3 DISCOVER 2 Clinical Trial Comparing Dalbavancin to Vancomycin & Li...	NASDAQ:DRTX	(MM)